Literature DB >> 384626

Neonatal septicaemia in Benin City, Nigeria. A review of 74 cases.

J A Omene.   

Abstract

Seventy four cases of neonatal septicaemia seen at the University of Benin Teaching Hospital (UBTH) over a 3-year period were analysed. The incidence was 6.1 per 1,000 live births. Fifty five percent of the infants were low birth weight. The predisposing perinatal problems were asphyxia, prolonged rupture of membrane and peripartum maternal fever. E. coli and Staphylococcus aureus were the most important aetiologic pathogens; both of which were associated with a high mortality rate. The overall mortality rate was 41.5%. On the basis of the organisms isolated and their sensitivity patterns, it is suggested that the initial treatment for neonatal septicaemia should include cloxacillin and gentamycin.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 384626

Source DB:  PubMed          Journal:  Trop Geogr Med        ISSN: 0041-3232


  5 in total

Review 1.  Aetiology and management of children with acute fever of unknown origin.

Authors:  G O Akpede; G I Akenzua
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

2.  Neonatal osteomyelitis in Nigerian infants.

Authors:  J A Omene; J C Odita; A A Okolo
Journal:  Pediatr Radiol       Date:  1984

3.  Sensitivity pattern among bacterial isolates in neonatal septicaemia in port Harcourt.

Authors:  Boma A West; Oliemen Peterside
Journal:  Ann Clin Microbiol Antimicrob       Date:  2012-03-26       Impact factor: 3.944

4.  Bacterial isolates from blood cultures of children with suspected septicaemia in Calabar, Nigeria.

Authors:  Martin M Meremikwu; Chukwuemeka E Nwachukwu; Anne E Asuquo; Joseph U Okebe; Simon J Utsalo
Journal:  BMC Infect Dis       Date:  2005-12-08       Impact factor: 3.090

5.  Prospective evaluation of the usefulness of C-reactive protein in the diagnosis of neonatal sepsis in a sub-Saharan African region.

Authors:  Boma A West; Oliemen Peterside; Rosemary O Ugwu; Augusta U Eneh
Journal:  Antimicrob Resist Infect Control       Date:  2012-06-01       Impact factor: 4.887

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.